Dcvision SRL
The score of Dcvision shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +751 % Total assets +946 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Dcvision's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 102,992 € | ||||
| Equity | 211,141 € | ||||
| Cash | 100,070 € | ||||
| EBITDA | 157,965 € | ||||
| Total assets | 443,302 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Dcvision's financial analysis
- Solvency47.6%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dcvision
Dcvision's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0600.863.530
- VAT number
- BE0600863530
- Peppol
- Registered · 0208:0600863530 · as of 30 Oct 2026
- Legal form
- SRL
- Incorporated
- 10 Mar 2015
- Registered office
- 9970 Kaprijke
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Dcvision (SRL) has been based in Kaprijke since 2015, active in: manufacture of other pharmaceutical products. For 2025, it reports a net profit of 102,992 € and equity of 211,141 €; its revenue is not published. Its solvency stands at 47.6%, above the median of its sector (47.2%).
Companies similar to Dcvision
Companies in the same business, of comparable size and area, outside its group.
- Exel Dental Manufacture of pharmaceutical preparations Braine-le-Comte · balance sheet 383,704 €
- Care4Excellence Manufacture of pharmaceutical preparations Overijse · balance sheet 307,250 €
- Pharmacie Ganser Retail sale of pharmaceutical products Villers-le-Bouillet · balance sheet 616,588 €
- AdipoPharma Belgique Manufacture of pharmaceutical preparations Charleroi · balance sheet 398,195 €
- Superbiotics Manufacture of other food products n.e.c. Éghezée · balance sheet 183,984 €
- NEIRYNCK en VOGT Manufacture of pharmaceutical preparations Schelle · balance sheet 310,017 €
- Apotheek Vandeperre LUT Retail sale of pharmaceutical products Meerhout · balance sheet 509,176 €
- Pharma Leyens Retail sale of pharmaceutical products Liège · balance sheet 311,356 €
Frequently asked questions about Dcvision
What is the revenue of Dcvision?
Dcvision files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dcvision?
In Belgium, the VAT number is the company number prefixed with BE: BE0600863530 for Dcvision, if the company is VAT-registered. Its company number (CBE) is 0600.863.530.
Where is the registered office of Dcvision?
According to the CBE register, the registered office of Dcvision is in 9970 Kaprijke.
What is the equity of Dcvision?
At the close of the 2025 financial year, the equity of Dcvision amounts to 211,141 €, a solvency of 47.6% of total assets.
Who manages Dcvision?
The register lists 1 active mandates at Dcvision. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dcvision
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →